Advertisement

Topics

CANTOS Trial Brings Unexpected CVD Promise For Novartis & Regeneron

09:00 EDT 22 Jun 2017 | SCRIP

Few expected the positive top-line results from CANTOS showing the Phase III cardiovascular disease study using canakinumab met the primary...

      

Related Stories

 

Original Article: CANTOS Trial Brings Unexpected CVD Promise For Novartis & Regeneron

NEXT ARTICLE

More From BioPortfolio on "CANTOS Trial Brings Unexpected CVD Promise For Novartis & Regeneron"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...